Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENOV · against 457 other Healthcare companies of similar size
Ranked #285 of 458 · scores higher than 37% of peers
Bars: peers in each 10-point band of the profitability score55 peers with a profitability score of 40–49, including ENOV · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ENOV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 433 reported | 2.7% | 5.3% | 41% | 33% | |
| Operating marginHigher is better · 429 reported | -0.8% | 7.1% | 31% | 33% | |
| Return on assetsHigher is better · 443 reported | 1.2% | 1.8% | 45% | 33% | |
| Return on equityHigher is better · 426 reported | -54.1% | 3.1% | 12% | Context only | |
| Gross marginHigher is better · 477 reported | 61.3% | 47.7% | 69% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 914M USD | 99 | 81 | |
| 282 | 1.2B USD | 41 | 42 | |
| 282 | 1.1B CAD (≈$807M) | 41 | 60 | |
| 285 | 4.3B CNY (≈$608M) | 40 | 20 | |
| 285 | 5.9B HKD (≈$757M) | 40 | 39 | |
| 285 | 1.2B USD | 40 | 46 | |
| 285 | 1.1B USD | 40 | 31 | |
| 285 | 1.5B EUR (≈$1.6B) | 40 | 44 | |
| 290 | 1.86T KRW (≈$1.3B) | 39 | 43 | |
| 290 | 6.0B CNY (≈$840M) | 39 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score